Calliditas Therapeutics AB
F:LC8A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Calliditas Therapeutics AB
F:LC8A
|
SE |
|
Pond Technologies Holdings Inc
F:4O0
|
CA |
|
S
|
SCSK Corp
F:QSU
|
JP |
|
Synairgen PLC
F:OMY
|
UK |
|
A
|
Anhui Expressway Co Ltd
F:HU7
|
CN |
|
Daio Paper Corp
F:DPR
|
JP |
|
Bong AB
F:20L
|
SE |
|
Astellas Pharma Inc
F:YPHA
|
JP |
|
S
|
Spire Healthcare Group PLC
F:S00
|
UK |
|
B
|
Brave Bison Group PLC
F:RT7
|
UK |
|
Hellenic Telecommunications Organization SA
F:OTES
|
GR |
|
B
|
Bank of East Asia Ltd
F:BOA
|
HK |
|
NGK Insulators Ltd
F:NGI
|
JP |
|
W
|
World Copper Ltd
F:7LY
|
CA |
|
DCM Holdings Co Ltd
F:889
|
JP |
|
C
|
China Aerospace International Holdings Ltd
F:CIOC
|
HK |
Shareholder Yield
Current shareholder yield for 
LC8A is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LC8A Price
Calliditas Therapeutics AB
| Average Annual Return | -16.12% |
| Standard Deviation of Annual Returns | 16.7% |
| Max Drawdown | -57% |
| Market Capitalization | 12.5B EUR |
| Shares Outstanding | 27 016 700 |
| Percentage of Shares Shorted |
N/A
|
